Literature DB >> 23881281

Curcumin induces apoptosis in human gastric carcinoma AGS cells and colon carcinoma HT-29 cells through mitochondrial dysfunction and endoplasmic reticulum stress.

Aili Cao1, Qi Li2, Peihao Yin2, Yang Dong1, Hailian Shi1, Li Wang2, Guang Ji3, Jianqun Xie4, Dazheng Wu5,6.   

Abstract

In the present study, we investigate the effect of curcumin, a major active component isolated from rhizomes of Curcuma longa, on the cytotoxicity of three human carcinoma cell lines (AGS, HT-29 and MGC803) in gastrointestinal tract and a normal gastric epithelial cell line GES-1, and the mechanism of curcumin-induced apoptosis. The results indicated that curcumin inhibited the gastrointestinal carcinoma cell growth in a dose-dependent manner and cytotoxicity was more towards the gastric carcinoma cell AGS and colon carcinoma cell HT-29 compared to normal gastric cell GES-1, and increased externalization of phosphatidylserine residue was observed by Annexin V/PI staining in the two cell lines. Treatment of AGS and HT-29 cells with curcumin enhanced the cleavage of procaspase-3, -7, -8 and -9. Meanwhile, curcumin induced endoplasmic reticulum (ER) stress and mitochondrial dysfunction as evidenced by up-regulation of CCAAT/enhancer binding protein homologous protein (CHOP), phosphorylation of JNK and down-regulation of SERCA2ATPase, release of cytochrome c, decrease of Bcl-2 and reduction of mitochondrial membrane potential in both AGS and HT-29 cells. Overexpression of bax, total JNK, phospho-FADD and total FADD were also observed in curcumin-treated HT-29 cells. Moreover, curcumin decreased cytosolic and ER Ca(2+), but increased mitochondrial Ca(2+) in the two cell lines. 2-Aminoethoxydiphenyl borate, an antagonist of inositol 1, 4, 5-triphosphate receptor, partly blocked curcumin-induced cytosolic Ca(2+) decrease in AGS and HT-29 cells. Additionally, carbonyl cyanide m-chlorophenylhydrazone, an inhibitor of mitochondrial Ca(2+) uptake, reversed curcumin-triggered AGS and HT-29 cells growth inhibition. siRNA to CHOP markedly reduced curcumin-induced apoptosis. These results suggest that curcumin can impact on ER stress and mitochondria functional pathways in AGS and HT-29 cells, death receptor pathway was also involved in curcumin-treated HT-29 cells, thus identifying specific well-defined molecular mechanisms that may be targeted by therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23881281     DOI: 10.1007/s10495-013-0871-1

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  24 in total

1.  Design, synthesis and in vitro cell-based evaluation of the anti-cancer activities of hispolon analogs.

Authors:  Neduri V Balaji; Modukuri V Ramani; Arabela G Viana; Leticia P Sanglard; Jason White; Vanisree Mulabagal; Crystal Lee; Theophilus J Gana; Nosa O Egiebor; Gottumukkala V Subbaraju; Amit K Tiwari
Journal:  Bioorg Med Chem       Date:  2015-03-21       Impact factor: 3.641

2.  Pterospermum acerifolium (L.) wild bark extract induces anticarcinogenic effect in human cancer cells through mitochondrial-mediated ROS generation.

Authors:  Surya Kant Tripathi; Bijesh K Biswal
Journal:  Mol Biol Rep       Date:  2018-09-28       Impact factor: 2.316

3.  Gemini Curcumin Suppresses Gastric Cancer AGS Cell Proliferation Through Modulation of lncRNA CCAT2 and c-Myc Genes.

Authors:  Nasim Jabbari; Salar Hafez Ghoran; Haniyeh Semsari; Bashdar Mahmud Hussen; Esmaeil Babaei
Journal:  Turk J Pharm Sci       Date:  2022-06-27

4.  Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxo-dodecanoyl)-L-homoserine lactone triggers mitochondrial dysfunction and apoptosis in neutrophils through calcium signaling.

Authors:  Pradeep Kumar Singh; Vivek Kumar Yadav; Manmohit Kalia; Deepmala Sharma; Deepak Pandey; Vishnu Agarwal
Journal:  Med Microbiol Immunol       Date:  2019-08-03       Impact factor: 3.402

5.  A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells.

Authors:  Ashok Kumar; Baljinder Singh; Girish Mahajan; Parduman R Sharma; Sandip B Bharate; Mubashir J Mintoo; Dilip M Mondhe
Journal:  Tumour Biol       Date:  2016-07-24

6.  Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy.

Authors:  Ai-Li Cao; Li Wang; Xia Chen; Yun-Man Wang; Heng-Jiang Guo; Shuang Chu; Cheng Liu; Xue-Mei Zhang; Wen Peng
Journal:  Lab Invest       Date:  2016-03-21       Impact factor: 5.662

7.  Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways.

Authors:  Fujiang Cao; Tao Liu; Yunqiang Xu; Dongdong Xu; Shiqing Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

8.  Curcumin differentially affects cell cycle and cell death in acute and chronic myeloid leukemia cells.

Authors:  Macario Martínez-Castillo; Nicolas Villegas-Sepúlveda; Marco A Meraz-Rios; Araceli Hernández-Zavala; Jaime Berumen; Mathew A Coleman; Lorena Orozco; Emilio J Cordova
Journal:  Oncol Lett       Date:  2018-02-23       Impact factor: 2.967

Review 9.  Therapeutic targeting of replicative immortality.

Authors:  Paul Yaswen; Karen L MacKenzie; W Nicol Keith; Patricia Hentosh; Francis Rodier; Jiyue Zhu; Gary L Firestone; Ander Matheu; Amancio Carnero; Alan Bilsland; Tabetha Sundin; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-04-11       Impact factor: 15.707

10.  EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells.

Authors:  Peng Zou; Yiqun Xia; Weiqian Chen; Xi Chen; Shilong Ying; Zhiguo Feng; Tongke Chen; Qingqing Ye; Zhe Wang; Chenyu Qiu; Shulin Yang; Guang Liang
Journal:  Oncotarget       Date:  2016-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.